Amal Therapeutics
Biotechnology ResearchGeneva, Switzerland11-50 Employees
Amal Therapeutics is a Biotechnology company located in 64 av., de la Roseraie, 1205 Geneva, Switzerland.
Insights
Gathering insights about Amal Therapeutics…
Similar companies to Amal Therapeutics
Oxford Biomedica
774
$100M$1BAgenus
296$50M$100MNorthwest Biotherapeutics
15$10MTransgene
209$50M$100MAdverum Biotechnologies
157$10M$50MAffimed
103$10M$50M
Amal Therapeutics Tech Stack
Amal Therapeutics uses 8 technology products and services including Google Analytics, WordPress, jQuery UI, and more. Explore Amal Therapeutics's tech stack below.
- Google AnalyticsAnalytics
- WordPressContent Management System
- jQuery UIJavascript Libraries
- ModernizrJavascript Libraries
- PWAMiscellaneous
- PHPProgramming Languages
- Adobe Tag ManagerTag Management
- ApacheWeb Servers
Media & News
Amal Therapeutics's Email Address Formats
Amal Therapeutics uses at least 1 format(s):
| Amal Therapeutics Email Formats | Percentage |
| First.Last@amaltherapeutics.com | 45% |
| Last.First@amaltherapeutics.com | 5% |
| First.MiddleLast@amaltherapeutics.com | 5% |
| First.Last@amaltherapeutics.com | 45% |
Frequently Asked Questions
Where is Amal Therapeutics's headquarters located?
Amal Therapeutics's main headquarters is located at 64 av., de la Roseraie Geneva, 1205 CH. The company has employees across 2 continents, including EuropeNorth America. What is Amal Therapeutics's official website and social media links?
Amal Therapeutics's official website is amaltherapeutics.com and has social profiles on LinkedIn.How much revenue does Amal Therapeutics generate?
As of September 2024, Amal Therapeutics's annual revenue reached $3.8M. What is Amal Therapeutics's SIC code NAICS code?
Amal Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Amal Therapeutics have currently?
As of September 2024, Amal Therapeutics has approximately 28 employees across 2 continents, including EuropeNorth America. Key team members include Chief Of Staff: A. K.Head Of Operations: D. K.Senior Director (translational Research): E. B.. Explore Amal Therapeutics's employee directory with LeadIQ.What industry does Amal Therapeutics belong to?
Amal Therapeutics operates in the Biotechnology Research industry. What technology does Amal Therapeutics use?
Amal Therapeutics's tech stack includes Google AnalyticsWordPressjQuery UIModernizrPWAPHPAdobe Tag ManagerApache. What is Amal Therapeutics's email format?
Amal Therapeutics's email format typically follows the pattern of . Find more Amal Therapeutics email formats with LeadIQ. How much funding has Amal Therapeutics raised to date?
As of September 2024, Amal Therapeutics has raised $33M in funding. The last funding round occurred on Nov 12, 2018 for $33M.When was Amal Therapeutics founded?
Amal Therapeutics was founded in 2012.
Company Overview
- Headquarters
- 64 av., de la Roseraie Geneva, 1205 CH
- Website
- amaltherapeutics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2012
- Employees
- 11-50
Media & News
Funding & Financials
- $33M
Amal Therapeutics has raised a total of $33M of funding over 9 rounds. Their latest funding round was raised on Nov 12, 2018 in the amount of $33M.
- $10M
Amal Therapeutics's revenue is in the range of $10M
Funding & Financials
- $33M
Amal Therapeutics has raised a total of $33M of funding over 9 rounds. Their latest funding round was raised on Nov 12, 2018 in the amount of $33M.
- $10M
Amal Therapeutics's revenue is in the range of $10M
Company Leadership
A. K.Chief Of Staff
D. K.Head Of Operations
E. B.Senior Director (translational Research)- D. G.Senior Clinical Trial Lead
- M. D.Cmc Team Leader
Employee Directory
- R. P.Senior Scientist
- M. R.Principal Scientist
- M. M.Scientist
- E. C.Scientist
- E. R.Scientist
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
